Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/1999
12/23/1999WO1999065904A1 Triazolo-pyridine derivatives as ligands for gaba receptors
12/23/1999WO1999065903A1 Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity
12/23/1999WO1999065900A1 Chemical synthesis of morpholine derivatives
12/23/1999WO1999065897A1 Inhibitors of glycogen synthase kinase 3
12/23/1999WO1999065895A1 Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same
12/23/1999WO1999065887A1 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
12/23/1999WO1999065880A1 Aryl alkanoylpyridazines
12/23/1999WO1999065877A1 Therapeutic biaryl derivatives
12/23/1999WO1999065876A1 Aryl substituted olefinic amines and their use as cholinergic receptors agonists
12/23/1999WO1999065867A1 Cyclic hydroxamic acids as metalloproteinase inhibitors
12/23/1999WO1999065571A2 Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders
12/23/1999WO1999065539A2 Tumescent solution
12/23/1999WO1999065509A1 Regulation of tyrosine hydroxylase
12/23/1999WO1999065508A1 Conformationally constrained backbone cyclized somatostatin analogs
12/23/1999WO1999065500A1 Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination
12/23/1999WO1999065495A1 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB
12/23/1999WO1999065492A1 Inhibition of serotonin reuptake
12/23/1999WO1999065491A1 Method of treatment
12/23/1999WO1999065490A2 Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders
12/23/1999WO1999065489A1 Methods for increasing levels of acetylcholine
12/23/1999WO1999065487A1 Inhibitors of serotonin reuptake
12/23/1999WO1999065478A1 Therapeutic compositions and methods of use
12/23/1999WO1999065449A2 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB
12/23/1999WO1999065309A1 Methods for increasing levels of acetylcholine
12/23/1999WO1999052516A3 Acylpeptide protease inhibitors to enhance cognitive function
12/23/1999DE19827679A1 New pyrazolo(3,4-d)pyrimidine derivative adenosine A3 receptor antagonists, used for treating epilepsy, asthma or allergy
12/23/1999DE19827387A1 Use of ligands of the high affinity binding site of diisopropyl-fluorophosphate in treatment of central nervous system disorders
12/23/1999DE19826843A1 Neue Imidazotriazolopyrimidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Imidazotriazolopyrimidine new, processes for their preparation and their use as medicaments
12/23/1999DE19826841A1 Arylalkanoylpyridazine Arylalkanoylpyridazine
12/23/1999CA2709735A1 Aryl substituted olefinic amines and their use as cholinergic receptors agonists
12/23/1999CA2677519A1 Aryl substituted olefinic amines and their use as cholinergic receptors agonists
12/23/1999CA2335724A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors
12/23/1999CA2335336A1 Inhibition of serotonin reuptake
12/23/1999CA2335322A1 Inhibitors of serotonin reuptake
12/23/1999CA2335295A1 Methods for increasing levels of acetylcholine
12/23/1999CA2335294A1 Inhibitors of transcription factor nf-.kappa.b
12/23/1999CA2335293A1 Inhibitors of transcription factor nf-.kappa.b
12/23/1999CA2335236A1 Method of treatment
12/23/1999CA2334900A1 Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity
12/23/1999CA2334836A1 Triazolo-pyridine derivatives as ligands for gaba receptors
12/23/1999CA2334817A1 Triazolo-pyrimidines as ligands for gaba receptors
12/23/1999CA2334528A1 Regulation of tyrosine hydroxylase
12/23/1999CA2334369A1 Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders
12/23/1999CA2334254A1 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
12/23/1999CA2333666A1 Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders
12/23/1999CA2333554A1 Cyclic hydroxamic acids as metalloproteinase inhibitors
12/23/1999CA2333453A1 Methods for increasing levels of acetylcholine
12/23/1999CA2331889A1 Nek-related and bub1-related protein kinases
12/23/1999CA2331382A1 Interaction of p27(kip1) with fkbp-12
12/23/1999CA2330840A1 Diagnostic method based on quantification of extramitochondrial dna
12/22/1999EP0965587A1 Tetrahydropyridinyl- and piperidinyl Inhibitors of serotonin reuptake
12/22/1999EP0965348A1 Process for gently recovering extract fractions from Hypericum perforatum L., pharmaceutical compositions containing them and the use thereof
12/22/1999EP0965343A2 Ziprasidone formulations
12/22/1999EP0964863A1 Oxazolidines as 5-ht2a-antagonists
12/22/1999EP0964860A1 Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions
12/22/1999EP0964854A1 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-thiones derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists
12/22/1999EP0964853A1 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists
12/22/1999EP0964849A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
12/22/1999EP0964691A1 Use of conantokins
12/22/1999EP0964683A1 Leukotriene antagonists for oral squamous cell carcinoma
12/22/1999EP0964679A1 Method for the treatment of neurological or neuropsychiatric disorders
12/22/1999EP0964677A1 Sustained analgesia achieved with buprenorphine
12/22/1999EP0839148B1 (r)-(z)-1-azabicyclo 2.2.1]heptan-3-one,o- 3-(3-methoxyphenyl)-2-propynyl]oxime maleate as a pharmaceutical agent
12/22/1999EP0758312B1 Substituted fused and bridged bicyclic compounds as therapeutic agents
12/22/1999EP0733033B1 Pharmaceutically active substituted aromatic compounds
12/22/1999EP0731795B1 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
12/22/1999EP0711167A4 Methods of enhancing opiate analgesic potency or detoxifying an opiate addict
12/22/1999EP0684953A4 Adenosine kinase inhibitors comprising lyxofuranosyl derivatives.
12/22/1999EP0659083B1 Prevention and treatment of peripheral neuropathy
12/22/1999CN1239435A Methods and compsns. for stimulating neurite growth using compounds with affinity for FKBP12 in combination with neurotrophic factors
12/22/1999CN1239434A Methods and compsns. for stimulating neurite growth using compounds with affinity for FKBP12 in combination with neurotrophic factors
12/22/1999CN1239433A Methods and compsns. for stimulating neurite growth using compounds with affinity for PKBP12 in combination with neurotrophic factors
12/22/1999CN1238984A Medicine for treating facial paralysis and its preparing method
12/22/1999CN1238951A Nafiverine injection
12/21/1999US6005116 Isoxazole compounds useful for the prophylaxis or treatment of nervous diseases
12/21/1999US6005010 Cardiovascular disorders, antiarrhythmia agents and antiischemic agents
12/21/1999US6004998 Flavonoid 6,8-dibromochrysin
12/21/1999US6004991 Compounds for cosmetics with enantiomorphs
12/21/1999US6004983 Analgesics; antiinflammatory, antiarthritic and antidiabetic agents
12/21/1999US6004970 Administering with nicotine and drug enhancer
12/21/1999US6004963 Tumor necrosis factor release inhibitors; immunomodulators
12/21/1999US6004961 1,4-disubstituted piperazines
12/21/1999US6004958 Compounds and methods for therapeutic intervention in preventing diabetic complications and procedures for assessing a diabetic's risk of developing complications and determining the efficacy of therapeutic intervention
12/21/1999US6004937 Treating muscular and nervous system disorders
12/21/1999US6004794 Human serine protease
12/21/1999US6004556 Staphylococcus aureus RSBU-1
12/21/1999CA2060624C Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
12/21/1999CA2035653C Neuroprotective 3-piperidino-4-hydrosychroman derivatives
12/21/1999CA2003422C Quinuclidines, their use as medicaments and processes for their preparation
12/21/1999CA1340855C Neurite-promoting factor and process for the manufacture thereof
12/16/1999WO1999064596A2 Proteins regulating gene expression
12/16/1999WO1999064426A1 Heterobicyclic and tricyclic nitric oxide synthase inhibitors
12/16/1999WO1999064423A1 Furopyridine derivatives and their therapeutical use
12/16/1999WO1999064422A1 Pyrido[2,3-b]indolizine derivatives and aza analogues thereof; crf1 specific ligands
12/16/1999WO1999064421A1 Acetylcholine enhancers
12/16/1999WO1999064420A1 β-CARBOLINE COMPOUNDS
12/16/1999WO1999064414A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
12/16/1999WO1999064412A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
12/16/1999WO1999064411A1 Tetrahydroquinoline derivatives as glycine antagonists
12/16/1999WO1999064403A1 1,5-benzodiazepine derivatives
1 ... 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 ... 1833